Sun Pharmaceutical Industries witnessed a significant improvement in the positive media coverage during the June 2018 quarter. Regulatory approvals and encouraging earnings led the positive news coverage for Sun Pharma in the June 2018 quarter.
At the same time, the volume of negative news has also dropped sharply in the same period. As a result, the long-term news sentiment has improved towards the end of the quarter.
Moreover, the improvement in news sentiment was also reflected in the recent rally in Sun Pharma’s stock price. Net-net, the news cycle was favorable for India’s leading drug maker in the June 2018 quarter.
[Compare screen: Sun Pharma – Share Price, News Volume, and Sentiment]
FiND is a first of its platform offering high-end media analytics by tracking news coverage patterns and analyzing movement in underlying sentiment in real-time for all listed and unlisted companies globally. Our media analytics platform helps corporate communications/ public relations executives to:
#1. Track media presence and tonality of the company, CXOs, and brands
#2. Gather competitive intelligence and benchmark against peers
#3. Analyse the effectiveness of media campaigns
#4. Gauge media reception of new product launches/initiatives
To know more about, FiND Media Analytics, email us at email@example.com